Valneva: Positive Phase 3 Results for COVID-19 Vaccine

2021-10-20T17:32:53+02:00October 20th, 2021|

Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 that successfully met both co-primary endpoints. Superior neutralizing antibody titer levels compared to active comparator vaccine, AstraZeneca’s AZD1222 (ChAdOx1-S). Neutralizing antibody seroconversion [...]

Go to Top